Science
Mechanism of Action
This extract is characterized by its significant content of total phenolics and flavonoids, which contribute to its potential to neutralize free radicals and mitigate oxidative stress. Bioactive phenylpropenoids such as eugenol and elemicin, isolated from the plant, have demonstrated anti-platelet activity, a mechanism linked to anti-inflammatory processes that could benefit skin conditions. Preliminary studies have also indicated very weak antiviral activity, though no antibacterial effects were observed.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Safety
Safety Profile
Specific safety assessments for Cymbopogon ambiguus Leaf Extract by regulatory bodies such as CIR or SCCS are not available. While FDA GRAS status exists for oils from different Cymbopogon species (e.g., Cymbopogon citratus) used as flavoring, this does not apply to this specific leaf extract, and cosmetic ingredients generally do not undergo pre-market FDA approval.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Due to the scarcity of specific research and clinical studies on Cymbopogon ambiguus Leaf Extract, its full potential and safety profile in skincare remain largely undefined, warranting further rigorous investigation.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources